Long-term complete remission with ipilimumab in metastatic castrate-resistant prostate cancer: case report of two patients

Overview of attention for article published in Journal for Immunotherapy of Cancer, April 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (88th percentile)
Above-average Attention Score compared to outputs of the same age and source (56th percentile)

So far, Altmetric has seen 39 X posts from 29 X users, with an upper bound of 68,373 followers.

RT @sitcancer: #JITC: Long-term complete remission with Ipilimumab in metastatic castrate-resistant prostate cancer: case report... https:/…

RT @sitcancer: #JITC: Long-term complete remission with Ipilimumab in metastatic castrate-resistant prostate cancer: case report... https:/…

RT @sitcancer: #JITC: Long-term complete remission with Ipilimumab in metastatic castrate-resistant prostate cancer: case report... https:/…

RT @sitcancer: #JITC: Long-term complete remission with Ipilimumab in metastatic castrate-resistant prostate cancer: case report... https:/…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 35 additional X posts.